Webinar | Cut Fermentation Cost Without Sacrificing Scale-Up
22nd May | 12 PM ET: Register Now

Rapport Therapeutics

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
2022
51-100
Boston, Massachusetts, United States
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

250.M

Last Funding Amount

150.M

Last Funding Date

23-08-2023

Startup Stage

IPO

Lead Investors

Cormorant Asset Management, Perceptive Advisors, ARCH Venture Partners, Fidelity, Third Rock Ventures

People

Founders

Something missing or incorrect on this page? Help us enrich this information